Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 27Lymphoma, Non-Hodgkin 25Lymphoma 20Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Leukemia 20Hodgkin Disease 14Central Nervous System Neoplasms 13Breast Neoplasms 13Hematologic Neoplasms 12Leukemia, Lymphocytic, Chronic, B-Cell 11Neuroblastoma 9Burkitt Lymphoma 9Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Myeloproliferative Disorders 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Biphenotypic, Acute 7Lymphoma, Follicular 6Graft vs Host Disease 6Dendritic Cell Sarcoma, Interdigitating 6Congenital Abnormalities 6Brain Neoplasms 6Blast Crisis 6Anemia, Refractory, with Excess of Blasts 6Testicular Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, B-Cell, Marginal Zone 5

Interventions

Cyclophosphamide 3fludarabine phosphate 2Whole-Body Irradiation 2Fentanyl 2thymoglobulin 1fludarabine 1Thiotepa 1Tacrolimus 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Melphalan 1Medical Marijuana 1Dexamethasone 1Busulfan 1Bortezomib 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anemia, Sickle Cell × Thiotepa × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡